Your browser doesn't support javascript.
loading
The use of thrombolytics in the management of complex pleural fluid collections.
Heimes, Jessica; Copeland, Hannah; Lulla, Aditya; Duldulao, Marjulin; Bahjri, Khaled; Zaheer, Salman; Wallen, Jason M.
Afiliação
  • Heimes J; Department of Thoracic and Cardiothoracic Surgery, Loma Linda University Medical Center, Loma Linda, California, USA.
  • Copeland H; Cardiothoracic Surgery Richmond, McGuire Veterans Affairs Medical Center, Richmond, VA, USA.
  • Lulla A; Department of Emergency Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Duldulao M; Weill Cornell Medical Center, New York Presbyterian Hospital, New York, USA.
  • Bahjri K; School of Public Health, Loma Linda University, Loma Linda, California, USA.
  • Zaheer S; Department of Thoracic and Cardiothoracic Surgery, Loma Linda University Medical Center, Loma Linda, California, USA.
  • Wallen JM; Department of Surgery, State University of New York Upstate Medical University, Syracuse, New York, USA.
J Thorac Dis ; 9(5): 1310-1316, 2017 May.
Article em En | MEDLINE | ID: mdl-28616283
ABSTRACT

BACKGROUND:

To determine the efficacy of thrombolytics for the management of complex pleural fluid collections.

METHODS:

We reviewed patients that received alteplase for persistent loculated pleural fluid collections after simple tube drainage between July 01, 2007 and November 01, 2012. Our alteplase protocol is 6 mg of alteplase in 50 mL of normal saline injected into the pleural chest tube. The chest tube is clamped for four hours and then opened. Normally this is repeated daily for 2 to 3 days (d).

RESULTS:

One hundred and three [103] patients were identified with 110 interventions. Sixty-eight (66%) of the patients were male, with ages ranging from 20-91 years (y), mean 57.2 y. Twenty (18.2%) patients were trauma patients, 60 (55%) had hypertension and 32 (35%) were smokers. Most patients had one of the following diagnoses 79.6% (82/110) loculated pleural fluid collection as a result of an empyema or 20.4% (21/110) retained hemothorax. The mean time from diagnosis to alteplase treatment for a hemothorax was 12.8 days (range, 1-32 days) and 16.2 days (range, 4-48 days) for an empyema. The mean duration of therapy was 2.2±1.4 days (1-11 days). The time from alteplase to chest tube removal was 4.5 days (1-21 days). Eleven of 103 (10.7%) patients required surgery including 3 video assisted decortications. The others had adequate radiographic resolution. Seventeen patients (16.5%) died, in the hospital of sepsis, respiratory failure, aortic injury, and cardiac arrest.

CONCLUSIONS:

Alteplase therapy is an effective alternative to surgery in most complex pleural fluid collections.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2017 Tipo de documento: Article